GLPwatch

Storage and Utilization of Glycogen by Mouse Liver during Adaptation to Nutritional Changes Are GLP-1 and PASK Dependent.

Nutrients · 2021

Last updated 2026-05-28

In a mouse study, a GLP-1 drug (exendin-4) and a protein called PASK were shown to influence how the liver stores and uses glycogen, a form of sugar, depending on whether the mice were fed or fasting. When mice were not fasting, the drug blocked certain liver processes, while under fasting conditions, it prevented sugar breakdown and led to abnormal sugar buildup in the liver. Mice lacking PASK also showed disrupted sugar regulation and liver responses to fasting.

AI summary of the abstract below.

JournalNutrients, 2021
Citations11
Relative citation ratio0.75
NIH percentile41
Molecules
Conditions studied Type 2 Diabetes, Obesity

Abstract

Glucagon-like peptide 1 (GLP-1) and PAS kinase (PASK) control glucose and energy homeostasis according to nutritional status. Thus, both glucose availability and GLP-1 lead to hepatic glycogen synthesis or degradation. We used a murine model to discover whether PASK mediates the effect of exendin-4 (GLP-1 analogue) in the adaptation of hepatic glycogen metabolism to nutritional status. The results indicate that both exendin-4 and fasting block the expression, and PASK deficiency disrupts the physiological levels of blood GLP1 and the expression of hepatic GLP1 receptors after fasting. Under a non-fasted state, exendin-4 treatment blocks AKT activation, whereby Glucokinase and Sterol Regulatory Element-Binding Protein-1c expressions were inhibited. Furthermore, the expression of certain lipogenic genes was impaired, while increasing Glucose Transporter 2 (GLUT2) and Glycogen Synthase (GYS). Moreover, exendin-4 treatment under fasted conditions avoided Glucose 6-Phosphatase expression, while maintaining high GYS and its activation state. These results lead to an abnormal glycogen accumulation in the liver under fasting, both in PASK-deficient mice and in exendin-4 treated wild-type mice. In short, exendin-4 and PASK both regulate glucose transport and glycogen storage, and some of the exendin-4 effects could therefore be due to the blocking of the expression.

Verbatim abstract via PubMed 34444712 ↗